Prosight Management as of Sept. 30, 2018
Portfolio Holdings for Prosight Management
Prosight Management holds 32 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Hanger Orthopedic | 13.9 | $25M | 1.2M | 20.83 | |
Teligent | 7.1 | $13M | 3.2M | 3.95 | |
Arena Pharmaceuticals | 6.3 | $11M | 244k | 46.02 | |
Macrogenics (MGNX) | 5.5 | $9.8M | 458k | 21.44 | |
BioMarin Pharmaceutical (BMRN) | 5.2 | $9.4M | 96k | 96.97 | |
Pieris Pharmaceuticals | 5.2 | $9.3M | 1.7M | 5.60 | |
Zimmer Holdings (ZBH) | 4.7 | $8.4M | 64k | 131.47 | |
Iovance Biotherapeutics (IOVA) | 4.5 | $8.0M | 715k | 11.25 | |
Intec Pharma | 4.2 | $7.6M | 1.3M | 5.65 | |
Reata Pharmaceuticals Inc Cl A | 3.6 | $6.6M | 80k | 81.75 | |
CIGNA Corporation | 3.4 | $6.1M | 29k | 208.24 | |
Allergan | 3.3 | $6.0M | 31k | 190.48 | |
Providence Service Corporation | 3.2 | $5.7M | 85k | 67.28 | |
Albireo Pharma | 3.0 | $5.4M | 163k | 32.96 | |
Viking Therapeutics (VKTX) | 2.7 | $4.8M | 274k | 17.42 | |
Sierra Oncology | 2.6 | $4.6M | 2.7M | 1.70 | |
Assembly Biosciences | 2.5 | $4.4M | 120k | 37.14 | |
Kura Oncology (KURA) | 2.5 | $4.4M | 254k | 17.50 | |
Shire | 2.4 | $4.2M | 23k | 181.28 | |
Eiger Biopharmaceuticals | 2.3 | $4.1M | 342k | 12.00 | |
Retrophin | 1.6 | $2.9M | 102k | 28.73 | |
Centene Corporation (CNC) | 1.6 | $2.9M | 20k | 144.81 | |
Axogen (AXGN) | 1.6 | $2.8M | 77k | 36.85 | |
Evolus (EOLS) | 1.4 | $2.6M | 139k | 18.62 | |
Catalyst Biosciences | 1.4 | $2.6M | 237k | 10.78 | |
Strongbridge Bioph shs usd | 1.1 | $2.1M | 424k | 4.85 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $1.4M | 325k | 4.40 | |
Noveliontherapeuti.. | 0.7 | $1.3M | 444k | 2.96 | |
Ovascience | 0.6 | $1.1M | 1.5M | 0.73 | |
Kezar Life Sciences (KZR) | 0.6 | $1.1M | 52k | 21.40 | |
Meiragtx Holdings (MGTX) | 0.3 | $527k | 39k | 13.60 | |
Aquinox Pharmaceuticals | 0.1 | $166k | 57k | 2.93 |